Anti-CD83 promotes IgG1 isotype switch in marginal zone B cells in response to TI-2 antigen

Immunobiology
Birte KretschmerAnke Osterloh

Abstract

CD83 is a transmembrane glycoprotein that is rapidly up-regulated on activated B cells. Although CD83 itself is incapable to transduce intracellular signaling, it acts as a negative regulator of B cell function. We have recently described that a single application of anti-CD83 antibody results in dramatically enhanced production of antigen-specific IgG1 but not other isotypes upon immunization of mice with the TI-2 model antigen (Ag) NIP-Ficoll. This effect was mediated by the binding of anti-CD83 to CD83 on the surface of B cells themselves. In the current study we show that administration of anti-CD83 enhances IgG1-production independent of IL-4. Application of anti-CD83 does not alter the proliferation and general expansion of NIP-specific B cells. In the presence of anti-CD83, immunized mice develop normal frequencies of plasmablasts in response to NIP-Ficoll of which an increased number produces IgG1. These cells localize in extrafollicular foci in the spleen of immunized mice and originate from the marginal zone B cell pool. Taken together, our results indicate that CD83 engagement in vivo does not generally enhance B cell activation but selectively promotes IgG1 class switch in marginal zone B cells in response to TI-2 Ag.

References

Feb 1, 1988·Immunological Reviews·C M SnapperW E Paul
Oct 1, 1986·European Journal of Immunology·F HoM Khan
Feb 1, 1996·European Journal of Immunology·K G SmithD M Tarlinton
Mar 1, 1997·Immunity·E SonodaK Rajewsky
May 5, 1998·International Archives of Allergy and Immunology·L B BacharierR S Geha
Jan 5, 1999·Scandinavian Journal of Immunology·J FayetteF Brière
Feb 9, 2000·The Journal of Experimental Medicine·C G de VinuesaI C MacLennan
Dec 1, 2001·The Journal of Biological Chemistry·Susmit SuvasJaved N Agrewala
Apr 17, 2002·Cell·Yoko FujimotoThomas F Tedder
May 30, 2002·Nature Reviews. Immunology·Flavius Martin, John F Kearney
Jan 28, 2003·European Journal of Immunology·Carola G VinuesaIan C M MacLennan
Sep 7, 2007·International Immunology·Yoshihiro KuwanoThomas F Tedder
Mar 11, 2008·Trends in Immunology·Minka Breloer, Bernhard Fleischer
Jun 12, 2008·International Immunology·Katja LüthjeMinka Breloer
Aug 5, 2008·Immunology Letters·Birte KretschmerMinka Breloer
Jan 12, 2011·The Journal of Experimental Medicine·Lina E TzeChristopher C Goodnow
Jun 4, 2013·International Immunology·Melanie UhdeAnke Osterloh

❮ Previous
Next ❯

Citations

Aug 10, 2016·Immunology and Cell Biology·Andrew M Collins
Apr 13, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kuan Y WongDavid J Munster

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Birte KretschmerMinka Breloer
European Journal of Immunology
Minka BreloerBernhard Fleischer
© 2021 Meta ULC. All rights reserved